SIGA News and Press, SIGA Technologies Inc. From 08/05/22

Tpoxx (tecovirimat), an antiviral medication from SIGA Technologies ( NASDAQ: SIGA ), will begin testing in humans as soon as September, Bloomberg reported. The drug is currently only approved for smallpox but is available as a treatment for smallpox under the U.S....

SIGA Technologies ( NASDAQ: SIGA ) reached a new 52-week on Friday as the monkeypox drug developer drew renewed investor interest a day after the U.S. declared the viral outbreak a public health emergency. The commercial-stage pharma company witnessed a ~23% decline in...

Making money with penny stocks in a recession Penny stocks can be a great way to make money in a recession or during normal economic conditions. When the stock market is down, investors are looking for opportunities to make money, and penny stocks can provide that opportunity. W...

Many investors likely hadn't heard of drugmaker Siga Technologies (NASDAQ: SIGA) even just a month ago. However, with shares of the company soaring more than 48% in July, blasting past the S&P 500 's gains of 9%, the stock is getting much more attention these days. Siga'...

The U.S. FDA is examining way to maximize limited supplies of the only approved monkeypox vaccine as well as boost access to an antiviral medicine that could see wider use for the virus, according to FDA Commissioner Robert Califf. His comments came at at Thursday afternoon news con...

SIGA Technologies press release ( NASDAQ: SIGA ): Q2 GAAP EPS of $0.03. Revenue of $16.7M (+92.0% Y/Y). Shares -3.2% . Starting in June 2022, procurement orders for oral TPOXX® from new international jurisdictions, as well as orders under existing contract...

- Approximately $9 Million of Product Sales in the Second Quarter, including First Oral TPOXX® Sale to the U.S. Department of Defense and Approximately $5 Million of International Sales – - Received Approximately $60 Million of International Orders for Or...

The Biden administration declared the current monkeypox outbreak a public health emergency on Thursday in a bid to marshal resources and raise awareness to contain the fast-spreading virus. Previously, The Washington Post reported the government plans, citing two officials. “...

Penny Stocks To Watch & More If You’re Concerned About Monkeypox Are you concerned about monkeypox? Even if you’re not, you might be interested in taking advantage of the speculative environment in the stock market today. If so, having a list of penny stocks and hi...

A group of public health officials from several federal agencies penned an editorial in the New England Journal of Medicine defending a recent U.S. FDA statement that SIGA Technologies' ( NASDAQ: SIGA ) Tpoxx (tecovirimat) has not demonstrated efficacy in humans fo...